Neuroimaging-based markers of bipolar disorder: evidence from two meta-analyses.
Josselin Houenou, Juliane Frommberger, Soufiane Carde...
https://pubmed.ncbi.nlm.nih.gov/21470688/Actively Recruiting
Led by Laureate Institute for Brain Research, Inc. · Updated on 2026-04-17
72
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating how emotional states change over time in people with bipolar disorder BD compared to healthy individuals. The study aims to understand the brain processes behind mood instability and whether boosting positive emotions can help stabilize these changes. It focuses on adults with BD type I or II who are currently depressed or in a mixed state, compared to healthy controls without psychiatric history. Participants complete two visits a preparation session with interviews and questionnaires, followed by a brain MRI session. During MRI, they undergo resting-state scans and a special task called the Think and Regulate Affective States Task TReAT. This task involves recalling personal positive and negative memories, rating emotions, and practicing strategies to amplify positive feelings. Physiological measures like heart rate and breathing are recorded during scanning. Throughout the study, participants fill out mood and emotion questionnaires, provide descriptions of autobiographical events, and rate their emotional experiences during and after MRI. Researchers analyze brain imaging and physiological data to decode emotional states and measure brain network stability. The main outcomes include tracking emotional state patterns and brain network changes during the tasks, helping to clarify how the brain supports emotion regulation in bipolar disorder.
CONDITIONS
Decoding Emotional Dynamics in Bipolar Disorder
M
Masaya Misaki Study Primary Investigator, Ph.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Laureate Institute for Brain Research, Inc.
Lead Sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | TReAT Task (Investigational Behavioral Intervention) | Current Mood Regulation Therapy (CBT/Medication) |
|---|---|---|
| What it is | A behavioral task where participants recall autobiographical memories, rate emotional states, and practice positive emotion regulation during fMRI scanning. Designed to decode emotional states and measure neural impact in bipolar disorder. | Mood regulation therapy, including regular sessions of cognitive-behavioral therapy or similar evidence-based psychotherapy, combined with medication management for bipolar depression. |
| Primary use | Experimental tool to decode emotional dynamics, evaluate neural responses to positive emotion regulation, and map brain state transitions in bipolar disorder. | Clinical management of depressive and mixed mood states by improving emotional regulation, reducing symptoms, and preventing relapse. |
| Evidence status | Investigational—no published clinical outcomes or efficacy data for this task in bipolar disorder. Results are ongoing; maturity limited to basic science measurements. | Supported by peer-reviewed studies showing psychotherapy and mood regulation therapies reduce depressive symptoms and improve emotional control in bipolar disorder and depression. |
| Important limitations | Unproven effectiveness; measures neural and behavioral changes, but clinical impact is unknown. Requires MRI compatibility and excludes participants with unstable medical, psychiatric, or neurocognitive conditions. | Therapy and medication outcomes vary; some individuals experience incomplete symptom relief or adverse events. Engagement and access to evidence-based psychotherapy may be limited in standard clinical practice. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for consent, psychiatric screening, and questionnaires
Duration - 1 day
Participants complete diagnostic interviews, questionnaires on mood and emotion, and recall personal autobiographical events to prepare for MRI tasks.
1 visit (in-person)
Duration - 1 day
Participants undergo MRI scans including resting-state and task-based fMRI while completing the Think and Regulate Affective States Task (TReAT), with concurrent physiological monitoring and emotional ratings.
1 visit (in-person) lasting up to 2 hours
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Josselin Houenou, Juliane Frommberger, Soufiane Carde...
https://pubmed.ncbi.nlm.nih.gov/21470688/Amal Jubran
https://pubmed.ncbi.nlm.nih.gov/26179876/Kyu-Man Han, Domenico De Berardis, Michele Fornaro...
https://pubmed.ncbi.nlm.nih.gov/29601896/Delfina Janiri, Sophia Frangou
https://pubmed.ncbi.nlm.nih.gov/36786111/D V Sheehan, Y Lecrubier, K H Sheehan...
https://pubmed.ncbi.nlm.nih.gov/9881538/June Gruber, Amanda L Purcell, Michael J Perna...
https://pubmed.ncbi.nlm.nih.gov/22866884/Charles T Taylor, Sonja Lyubomirsky, Murray B Stein
https://pubmed.ncbi.nlm.nih.gov/28060463/Abigail Ortiz, Martin Alda
https://pubmed.ncbi.nlm.nih.gov/30371048/S Nolen-Hoeksema, J Morrow
https://pubmed.ncbi.nlm.nih.gov/1890582/Shi Gu, Fabio Pasqualetti, Matthew Cieslak...
https://pubmed.ncbi.nlm.nih.gov/26423222/Laureate Institute for Brain Research, Inc.
Lead Sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborating Sponsor